🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 19

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 19 of 20
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Nov 10, 2024 at 9:51 PM#91
LabKate said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Bookmarking. The distinction being drawn above is the one nobody else makes.

Last edited: Nov 10, 2024 at 11:51 PM
34 9pete_RVA, CarlaRPh_TPA, steph_laguna and 31 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Nov 14, 2024 at 6:28 AM#92

Worth restating a point from upthread for anyone joining at this page:

A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator. Three questions, and they resolve most disagreements in these threads.

33 8andrew_nyc, Dr.EndoEP, GraceAZ_72 and 30 others
Reply Quote Save Share Report
B12Beth
Member
289
890
Oct 2024
Maryland
Nov 17, 2024 at 3:03 PM#93
Dr.ReproEndo said:
A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator.

Adding a me-too, because a thread of one person's experience is not much use.

Last edited: Nov 17, 2024 at 6:03 PM
32 7DanielChem_CHI, marco_milano, pam_columbus and 29 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Nov 20, 2024 at 11:36 PM#94
Dr.ReproEndo said:
A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator.

Coming at Dr.ReproEndo’s question from a different direction. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

31 6wanda_boise, NurseAsh_DET, BenResearch_OR and 28 others
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Nov 24, 2024 at 8:07 AM#95

Worth restating a point from upthread for anyone joining at this page:

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

30 5cory_ATX, lori_vegas, Dr.PulmRoch and 27 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register